Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic natural killer cells CHM 0201

A preparation of off-the-shelf (OTS) allogeneic, natural killer (NK) cells that are activated and expanded ex vivo, with potential cytolytic and antineoplastic activities. Upon administration, allogeneic NK cells CHM 0201 recognize and lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic NK cells CHM 0201 allogeneic NKs CHM 0201
Code name:	CHM 0201 CHM-0201 CHM0201

allogeneic natural killer cells CHM 0201

Search NCI's Drug Dictionary